Provided by Tiger Fintech (Singapore) Pte. Ltd.

Corcept Therapeutics

69.27
+4.597.10%
Post-market: 69.270.0200+0.03%18:41 EDT
Volume:1.80M
Turnover:123.94M
Market Cap:7.31B
PE:56.32
High:70.73
Open:66.78
Low:65.77
Close:64.68
Loading ...
Sep 01, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 01, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 15, 2023

Correspondence

Form CORRESP - Correspondence
Aug 14, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 14, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 07, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 07, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 02, 2023

Major Issues Report

Form 8-K - Current report
Aug 02, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 06, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 25, 2023

Major Issues Report

Form 8-K - Current report
May 09, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
May 03, 2023

Major Issues Report

8-K - Current report
May 03, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 28, 2023

Major Issues Report

8-K - Current report
Feb 28, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 15, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2023

Major Issues Report

8-K - Current report
Feb 09, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals